Vimela Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Liquidation

Vimela Therapeutics General Information

Description

Operator of an orthogonal company intended to provide immunotherapy for the treatment of vitiligo. The company is currently operating in Stealth Mode.

Contact Information

Website
www.vimelatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • The Cambridge Partnership The Dorothy Hodgkin Building
  • Babraham Research Campus
  • Cambridge CB22 3FH
  • England, United Kingdom
Primary Industry
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • The Cambridge Partnership The Dorothy Hodgkin Building
  • Babraham Research Campus
  • Cambridge CB22 3FH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vimela Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 30-Jun-2026 Completed Bankruptcy: Liquidation
1. Early Stage VC 31-Jul-2023 Completed Stealth
To view Vimela Therapeutics’s complete valuation and funding history, request access »

Vimela Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Vimela Therapeutics’s complete cap table history, request access »

Vimela Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Vimela Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025253347-A1 Topical delivery of melanocortin-1 receptor agonists formulations Pending 07-Jun-2024

Ready to get started?

Request a free trial

Vimela Therapeutics FAQs

  • When was Vimela Therapeutics founded?

    Vimela Therapeutics was founded in 2021.

  • Where is Vimela Therapeutics headquartered?

    Vimela Therapeutics is headquartered in Cambridge, United Kingdom.

  • What industry is Vimela Therapeutics in?

    Vimela Therapeutics’s primary industry is Therapeutic Devices.

  • Is Vimela Therapeutics a private or public company?

    Vimela Therapeutics is a Private company.

  • What is Vimela Therapeutics’s current revenue?

    The current revenue for Vimela Therapeutics is .

  • How much funding has Vimela Therapeutics raised over time?

    Vimela Therapeutics has raised $11M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process